Lantern Pharma, Inc. (LTRN)
0.6354
-0.01
(-0.83%)
USD |
NASDAQ |
Oct 23, 16:00
0.622
-0.01
(-2.11%)
After-Hours: 20:00
Lantern Pharma EPS Diluted (Quarterly) : -0.5693 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5693 |
| March 31, 2026 | -0.2958 |
| December 31, 2025 | -0.362 |
| September 30, 2025 | -0.3856 |
| June 30, 2025 | -0.4016 |
| March 31, 2025 | -0.4207 |
| December 31, 2024 | -0.5448 |
| September 30, 2024 | -0.4186 |
| June 30, 2024 | -0.461 |
| March 31, 2024 | -0.5065 |
| December 31, 2023 | -0.3876 |
| September 30, 2023 | -0.2912 |
| June 30, 2023 | -0.4372 |
| March 31, 2023 | -0.3562 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3114 |
| September 30, 2022 | -0.2089 |
| June 30, 2022 | -0.4148 |
| March 31, 2022 | -0.379 |
| December 31, 2021 | -0.3182 |
| September 30, 2021 | -0.3624 |
| June 30, 2021 | -0.2072 |
| March 31, 2021 | -0.2434 |
| December 31, 2020 | -0.4655 |
| September 30, 2020 | -0.2737 |
| June 30, 2020 | -0.134 |
| March 31, 2020 | -0.0762 |
| June 30, 2019 | -0.1012 |
| March 31, 2019 | -0.0725 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.072M |
| Total Expenses (Quarterly) | 7.072M |
| Enterprise Value | 0.7855M |
| Earnings Yield | -253.8% |
| Normalized Earnings Yield | -234.95 |